Hypertension artérielle réfractaire au traitement due au syndrome d'apnées du sommeil et à la prise de médicaments [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].

Détails

Ressource 1Télécharger: RMS_idPAS_D_ISBN_pu2012-01s_sa07_art07.pdf (1601.85 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_38BC7BD03937
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Hypertension artérielle réfractaire au traitement due au syndrome d'apnées du sommeil et à la prise de médicaments [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Waeber B., Feihl F.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
8
Numéro
323
Pages
28-30
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Résumé
Treatment-resistant hypertension is still common despite the availability of several types of antihypertensive agents acting by different mechanisms. The existence of refractory hypertension should lead to rule out "white-coat hypertension", poor adherence to prescribed drugs as well as classical causes of secondary hypertension such as renal artery stenosis, primary aldosteronism, pheochromocytoma and renal disease. It is also important to consider the possible existence of obstructive sleep apnea or the regular intake of vasopressive drugs or substances.
Mots-clé
Adrenal Gland Neoplasms/complications, Antihypertensive Agents/therapeutic use, Blood Pressure Monitoring, Ambulatory, Comorbidity, Humans, Hyperaldosteronism/complications, Hypertension/drug therapy, Hypertension/etiology, Kidney Diseases/complications, Medication Adherence, Pheochromocytoma/complications, Renal Artery Obstruction/complications, Risk Factors, Sleep Apnea, Obstructive/complications, Sleep Apnea, Obstructive/drug therapy, Vasoconstrictor Agents/adverse effects, White Coat Hypertension/diagnosis
Pubmed
Création de la notice
20/03/2012 15:32
Dernière modification de la notice
05/11/2024 7:17
Données d'usage